eagle-i University of Hawaii at ManoaUniversity of Hawaii at Manoa
See it in Search
This page is a preview of the following resource. Continue onto eagle-i search using the button on the right to see the full record.

Randomized placebo-controlled trial of acetyl-L-carnitine (ALC) for the prevention of taxane induced neuropathy phase III

eagle-i ID

http://hawaii.eagle-i.net/i/00000130-dde3-8aa9-9953-50a980000000

Resource Type

  1. Clinical trial

Properties

  1. ClinicalTrials.gov url
    http://www.clinicaltrials.gov/ct2/show/NCT00775645?term=S0715&rank=1
  2. Intervention
    Placebo
  3. Intervention
    Acetyl-L-carnitine
  4. Additional Topic(s)
    Neuralgia
  5. Additional Topic(s)
    Neuropathy
  6. Resource Description
    This randomized phase III trial is studying acetyl-L-carnitine to see how well it works compared with a placebo in preventing neuropathy in women with stage I, stage II, or stage III breast cancer undergoing chemotherapy.
  7. Contact
    Berenberg, Jeffrey
  8. PI
    Berenberg, Jeffrey
  9. Topic
    breast cancer
  10. Funded by
    SWOG
  11. Phase
    Phase 3 clinical trial
  12. Performed by
    Clinical Protocol & Data Management Shared Resource
 
RDFRDF
 
Provenance Metadata About This Resource Record
Copyright © 2016 by the President and Fellows of Harvard College
The eagle-i Consortium is supported by NIH Grant #5U24RR029825-02 / Copyright 2016